Literature DB >> 21898033

Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population.

Maria E Czira1, Heike Wersching, Bernhard T Baune, Klaus Berger.   

Abstract

A large number of studies have examined associations between brain-derived neurotrophic factor (BDNF) gene polymorphisms and depressive symptoms. However, results still remain controversial. Recent studies suggested a significant age and gender effect on the heritability of depression. The potential neurobiological pathways that could possibly mediate this relationship have not been examined so far. Since BDNF is involved in the regulation of neurotransmitter production, a mediating role of neurotransmitters seems plausible. The present study aims to examine the association between three common BDNF single-nucleotid polymorphisms (SNPs; rs7103411, rs7124442, and rs6265) and depressive symptoms in a community-based elderly population taking into account the serum levels of four neurotransmitters, serotonin, dopamine, adrenalin, and noradrenalin, as potential mediating factors. We also examined whether age and gender had a modifying effect on this association. We collected and analyzed the genetic and laboratory data as well as Center for Epidemiologic Studies-Depression scores of 350 community-dwelling elderly individuals (aged 65+ years). We found that the BDNF rs6265 polymorphism was related to the severity of depressive symptoms, and that this association was independent of neurotransmitter levels. Stratified analyses showed that this association was restricted to older individuals (≥74 years) and men. The associations of SNPs rs7103411 or rs7124442 SNP with depressive symptoms were not statistically significant. This study importantly adds to the existing literature by affirming previous assumptions on an age and gender difference in the relation between BDNF genotype and depression. We moreover first-time report a missing mediating role of neurotransmitters in this association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898033      PMCID: PMC3528367          DOI: 10.1007/s11357-011-9313-6

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  60 in total

Review 1.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

2.  Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.

Authors:  J M Mercader; M Ribasés; M Gratacòs; J R González; M Bayés; R de Cid; A Badía; F Fernández-Aranda; X Estivill
Journal:  Genes Brain Behav       Date:  2007-03-21       Impact factor: 3.449

Review 3.  Sexual dimorphism in the mammalian limbic system.

Authors:  M D Madeira; A R Lieberman
Journal:  Prog Neurobiol       Date:  1995-03       Impact factor: 11.685

4.  Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input.

Authors:  P O'Donnell; A A Grace
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

5.  Monoamine metabolism in human brain.

Authors:  D S Robinson; T L Sourkes; A Nies; L S Harris; S Spector; D L Bartlett; I S Kaye
Journal:  Arch Gen Psychiatry       Date:  1977-01

6.  Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease.

Authors:  R Huang; J Huang; H Cathcart; S Smith; S E Poduslo
Journal:  J Med Genet       Date:  2007-02       Impact factor: 6.318

7.  Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.

Authors:  L Pezawas; A Meyer-Lindenberg; A L Goldman; B A Verchinski; G Chen; B S Kolachana; M F Egan; V S Mattay; A R Hariri; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

Review 8.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

9.  Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Authors:  B Borroni; S Archetti; C Costanzi; M Grassi; M Ferrari; A Radeghieri; L Caimi; C Caltagirone; M Di Luca; A Padovani
Journal:  Neurobiol Aging       Date:  2008-01-07       Impact factor: 4.673

10.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  10 in total

1.  The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Authors:  Yu Pei; Alicia K Smith; Yongjun Wang; Yanli Pan; Jian Yang; Qi Chen; Weigang Pan; Feng Bao; Lisha Zhao; Changle Tie; Yizheng Wang; Jian Wang; Wenfeng Zhen; Jinxia Zhou; Xin Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-18       Impact factor: 3.568

2.  Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms.

Authors:  Rong Jiang; Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Redford B Williams
Journal:  J Psychiatr Res       Date:  2012-11-08       Impact factor: 4.791

3.  Dysregulation of the SNARE-binding protein Munc18-1 impairs BDNF secretion and synaptic neurotransmission: a novel interventional target to protect the aging brain.

Authors:  Young Il Lee; Yun Gi Kim; Hee Jang Pyeon; Jin Chul Ahn; Sreemathi Logan; Albert Orock; Kyeung Min Joo; Andrea Lőrincz; Ferenc Deák
Journal:  Geroscience       Date:  2019-04-30       Impact factor: 7.713

Review 4.  Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology.

Authors:  Van Thuan Nguyen; Braxton Hill; Naiya Sims; Aaron Heck; Marcus Negron; Claire Lusk; Cristi L Galindo
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

5.  No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Authors:  Richard Musil; Peter Zill; Florian Seemüller; Brigitta Bondy; Michael Obermeier; Ilja Spellmann; Wolfram Bender; Mazda Adli; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Wolfgang Maier; Marcella Rietschel; Dan Rujescu; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-11       Impact factor: 5.270

6.  Blood BDNF level is gender specific in severe depression.

Authors:  Anatoly Kreinin; Serah Lisson; Elimelech Nesher; Jenny Schneider; Josef Bergman; Kamal Farhat; Joseph Farah; Flavio Lejbkowicz; Gal Yadid; Leon Raskin; Igor Koman; Albert Pinhasov
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  GSK-3β and BDNF genes may not be associated with venlafaxine treatment response in Chinese of Han ethnicity.

Authors:  Qianqian Sun; Fan Yuan; Decheng Ren; Gaini Ma; Fengping Yang; Xi Wu; Lin He; Guang He
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-07       Impact factor: 2.570

Review 8.  The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections.

Authors:  Andrea László; Lilla Lénárt; Lilla Illésy; Andrea Fekete; János Nemcsik
Journal:  J Neural Transm (Vienna)       Date:  2019-02-14       Impact factor: 3.575

9.  Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder.

Authors:  Hongyan Wang; Yingquan Zhang; Mingqi Qiao
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

10.  Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents.

Authors:  Teruo Hashimoto; Kento Fukui; Hikaru Takeuchi; Susumu Yokota; Yoshie Kikuchi; Hiroaki Tomita; Yasuyuki Taki; Ryuta Kawashima
Journal:  Cereb Cortex       Date:  2016-01-31       Impact factor: 5.357

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.